Intas Pharmaceuticals has completed its acquisition of the UDENYCA (pegfilgrastim-cbqv) business from Coherus BioSciences Inc ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Arcutis Biotherapeutics Inc. has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the ...

Increases its competitiveness in the field of drug containment solutions and builds the largest ampoule manufacturing ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, has partnered with ...

Rivus Pharmaceuticals, Inc., announced the expansion of its leadership team and the opening of a South San Francisco office ...

Source BioScience UK Ltd, a provider of genomic services and histopathology diagnostics, has acquired Cambridge Clinical ...

Curium has acquired Nucleis, a specialist in GMP manufacturing and distribution of PET radiopharmaceutical drugs.

In his new role, Chen will enhance shareholder value and guide Harbour BioMed through its next phase of strategic development ...

PharmaLogic Holdings Corp., a CDMO specializing in radiopharmaceuticals, has agreed to acquire a majority stake in Agilera ...

The Hopewell facility offers an integrated approach to manufacturing with in-house analytical testing, method development, ...